EUVIMEDEUVIMED entdecken
Crossref

Development and In vitro kinetic evaluation of PEG-chitosan biohybrid micelles loading CBD with bile acid/quercetin as surface modifiers for colon cancer therapy

Qurat Ul Ain Haidery, Bo Han, Xingyuan Ma, Wenyun Zheng

Archives of Biochemistry and Biophysics · 2026

DOI: 10.1016/j.abb.2025.110711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026. Verfasst von Qurat Ul Ain Haidery und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, PR China. Hauptthemen laut MEDLINE: Quercetin, Chitosan, Micelles, Colonic Neoplasms. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, National Key Research and Development Program of China Stem Cell and Translational Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment for colon cancer is an intricate endeavor that demands innovative strategies for increasing the efficacy while lowering mortality and adverse effects. This study investigates the viability of delivering CBD to colon cancer cells by employing biohybrid micelles for oral delivery. These micelles are made of polyethylene glycol (PEG) and chitosan with bile acid and quercetin on the surface to synergistically increase CBD's anticancer benefits at lower doses and with fewer adverse effects. Chitosan's mucoadhesion and penetration facilitate PEG controlled release. The morphology, crystalline nature, stability, encapsulation efficiency (EE = 77.3 % ± 2 %), and composition of the biohybrid micelles are examined by using SEM, TEM, XRD, HPLC, FTIR, and TGA. IC50 values in μM (HCT116: 9.871 ± 0.244, HT29: 17.110 ± 2.515, Caco-2: 20.023 ± 2.685), colon cancer cell lines showed treatment with these micelles reduced cell survival in a dose-dependent manner relative to free CBD. Apoptosis investigations revealed increased caspase-3/7 activity by biohybrid micelles along with upregulation of Bax expression and downregulation of Bcl-2 expression confirmed by ELISA. Efficiency of component release from biohybrid micelles at varying pH levels is assessed after 72 h at pH 1.2, 6.8, and 7.4 (n ≥ 3). Drug release rates: Bile acid surpasses quercetin, which exceeds CBD (p < 0.05). This innovative drug delivery technique improves CBD colon cancer treatment by combining controlled release with quercetin synergy, laying a foundation for clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinChitosanMicellesColonic NeoplasmsBile Acids and SaltsPolyethylene GlycolsAntineoplastic AgentsHumansApoptosisDrug CarriersCell SurvivalKineticsCaco-2 CellsHCT116 CellsDrug LiberationHT29 Cells

Stichwörter der Autor:innen

BHM (biohybrid micelles)Cannabidiol (CBD) deliveryColon-targeted therapyPolyethylene glycol (PEG)quercetin loading

Substanzen

QuercetinChitosanMicellesBile Acids and SaltsPolyethylene GlycolsDrug CarriersAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, PR China.
  • Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, PR China.
  • State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, PR China. Electronic address: maxy@ecust.edu.cn.
  • Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, PR China. Electronic address: zwy@ecust.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • National Key Research and Development Program of China Stem Cell and Translational Research

Zitieren

APA

Haidery, Q. U. A., Han, B., Ma, X., & Zheng, W. (2026). Development and In vitro kinetic evaluation of PEG-chitosan biohybrid micelles loading CBD with bile acid/quercetin as surface modifiers for colon cancer therapy. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110711

Vancouver

Haidery QUA, Han B, Ma X, Zheng W. Development and In vitro kinetic evaluation of PEG-chitosan biohybrid micelles loading CBD with bile acid/quercetin as surface modifiers for colon cancer therapy. Archives of Biochemistry and Biophysics. 2026. doi:10.1016/j.abb.2025.110711

BibTeX
@article{Haidery2026,
  author = {Haidery, Qurat Ul Ain and Han, Bo and Ma, Xingyuan and Zheng, Wenyun},
  title = {Development and In vitro kinetic evaluation of PEG-chitosan biohybrid micelles loading CBD with bile acid/quercetin as surface modifiers for colon cancer therapy},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2026},
  doi = {10.1016/j.abb.2025.110711}
}
Kostenlos starten →